Skip to content

lncRNA TOPORS-AS1 as a Biomarker for Ovarian Cancer Prognosis and Potential Treatment Target

Investigating biomarkers for prediction of outcome and treatment of clinical and pathological features of breast and ovarian cancers

Published: 4th June 2021
lncRNA TOPORS-AS1 as a Biomarker for Ovarian Cancer Prognosis and Potential Treatment Target
Header image is purely illustrative. Source: motortion, stock.adobe.com/uk/182073500
IP Status
  • No patent
  • Know-how based
Seeking
  • Development partner
  • Commercial partner
  • Seeking investment